GLOBUS MEDICAL INC - Class A Stock (GMED)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Class A Stock
Symbol
GMED on NYSE
Shares outstanding
115,244,363
Price per share
$87.31
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
115,864,744
Total reported value
$6,650,931,098
% of total 13F portfolios
0.01%
Share change
+1,335,263
Value change
+$67,431,063
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
486
Price from insider filings
$88.85
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GLOBUS MEDICAL INC - Class A Stock (GMED) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 9.1% +16% $778,991,964 -$11,095,352 10,487,237 -1.4% BlackRock, Inc. 31 Mar 2025
JANUS HENDERSON GROUP PLC 6.1% +5% $522,135,958 +$30,787,723 7,029,294 +6.3% JANUS HENDERSON GROUP PLC 31 Mar 2025
As of 30 Sep 2025, GLOBUS MEDICAL INC - Class A Stock (GMED) has 486 institutional shareholders filing 13F forms. They hold 115,864,744 shares. .

Top 25 institutional shareholders own 63% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.2% 10,605,747 -0.96% 0.01% $607,391,131
BlackRock, Inc. 9.1% 10,533,319 -2.1% 0.01% $603,243,175
JANUS HENDERSON GROUP PLC 6.6% 7,552,637 -8% 0.2% $432,539,891
JPMORGAN CHASE & CO 3.2% 3,681,957 +10% 0.01% $210,865,683
Sculptor Capital LP 3% 3,500,000 +27% 2.8% $200,445,000
STATE STREET CORP 3% 3,461,610 -0.34% 0.01% $198,246,405
Burgundy Asset Management Ltd. 3% 3,460,983 -0.59% 2% $212,054,428
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.4% 2,819,165 +17% 0.42% $161,453,580
Madison Avenue Partners, LP 2.2% 2,548,163 +49% 8.7% $145,933,295
GENEVA CAPITAL MANAGEMENT LLC 1.8% 2,083,939 +0.06% 2% $119,347,176
GEODE CAPITAL MANAGEMENT, LLC 1.8% 2,062,975 +3.5% 0.01% $118,168,087
ALLIANCEBERNSTEIN L.P. 1.8% 2,055,183 +1304% 0.04% $117,700,330
DIMENSIONAL FUND ADVISORS LP 1.7% 2,011,104 +72% 0.02% $115,166,469
GW&K Investment Management, LLC 1.5% 1,777,431 -3.9% 0.9% $101,793,000
MARSHALL WACE, LLP 1.5% 1,711,909 +8.3% 0.11% $98,041,030
HAWK RIDGE CAPITAL MANAGEMENT LP 1.4% 1,569,235 -26% 4.3% $89,870,088
Champlain Investment Partners, LLC 1.3% 1,446,614 +34% 0.62% $82,847,584
Van Berkom & Associates Inc. 1.2% 1,333,111 +3.8% 2.2% $76,347,000
MANUFACTURERS LIFE INSURANCE COMPANY, THE 1.1% 1,288,128 -12% 0.06% $73,771,091
Vestal Point Capital, LP 1.1% 1,250,000 +150% 3.2% $71,587,500
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1% 1,203,708 +2.1% 0.01% $68,936,357
AXA Investment Managers S.A. 1% 1,202,828 0% 0.19% $68,885,959
ArrowMark Colorado Holdings LLC 1% 1,202,488 +25% 1.3% $68,866,488
Boston Trust Walden Corp 1% 1,185,461 0.5% $67,891,352
Global Alpha Capital Management Ltd. 0.99% 1,145,591 +8.6% 3.7% $65,607,997

Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 567,002 $49,637,218 -$4,050,166 $87.31 22
2025 Q3 115,864,744 $6,650,931,098 +$67,431,063 $57.27 486
2025 Q2 114,075,801 $6,730,550,265 +$195,769,905 $59.02 477
2025 Q1 109,316,760 $7,995,784,946 -$8,993,446 $73.20 506
2024 Q4 108,881,625 $9,006,038,986 +$195,338,163 $82.71 493
2024 Q3 106,223,481 $7,602,679,013 -$457,926,565 $71.54 443
2024 Q2 112,752,353 $7,722,130,519 +$131,340,892 $68.49 444
2024 Q1 111,425,542 $5,976,649,577 +$253,569,332 $53.64 433
2023 Q4 127,628 $6,801,295 -$7,390,941 $53.29 3
2023 Q3 107,742,793 $5,350,161,163 +$1,338,694,985 $49.65 416
2023 Q2 79,903,334 $4,756,281,758 +$359,563,066 $59.54 371
2023 Q1 73,314,856 $4,151,921,677 -$176,325,275 $56.64 375
2022 Q4 75,411,729 $5,599,365,744 +$85,497,442 $74.27 376
2022 Q3 73,808,673 $4,398,149,861 +$93,550,349 $59.57 348
2022 Q2 70,578,680 $3,959,417,115 +$108,533,666 $56.14 341
2022 Q1 69,201,978 $5,105,524,096 +$80,718,400 $73.78 359
2021 Q4 68,078,617 $4,915,761,681 +$7,719,969 $72.20 364
2021 Q3 67,430,361 $5,169,445,951 -$66,319,216 $76.62 378
2021 Q2 67,586,604 $5,240,597,769 +$20,314,807 $77.53 350
2021 Q1 67,103,735 $4,138,372,735 +$55,774,126 $61.67 335
2020 Q4 66,582,479 $4,342,368,324 +$138,223,236 $65.22 341
2020 Q3 64,357,802 $3,186,880,401 -$114,362,480 $49.52 333
2020 Q2 65,649,560 $3,129,926,495 -$231,576,809 $47.71 307
2020 Q1 62,197,328 $2,644,796,431 +$135,023,940 $42.53 262
2019 Q4 66,280,038 $3,901,938,928 -$37,480,114 $58.88 301
2019 Q3 67,376,470 $3,442,882,161 +$26,071,788 $51.12 261
2019 Q2 67,888,454 $2,871,785,269 +$109,567,188 $42.30 250
2019 Q1 65,898,868 $3,253,957,532 -$65,497,416 $49.41 261
2018 Q4 68,231,059 $2,952,446,951 +$98,821,270 $43.28 297
2018 Q3 64,770,635 $3,674,886,472 +$86,998,145 $56.76 308
2018 Q2 63,644,338 $3,211,619,881 +$142,184,996 $50.46 283
2018 Q1 61,964,717 $3,079,267,072 -$55,499,493 $49.82 277
2017 Q4 63,096,432 $2,591,009,259 -$136,441,326 $41.10 253
2017 Q3 67,529,162 $2,007,138,651 +$104,298,194 $29.72 242
2017 Q2 63,912,936 $2,113,531,840 -$13,340,766 $33.15 240
2017 Q1 66,281,493 $1,963,259,202 +$212,206,754 $29.62 237
2016 Q4 63,812,102 $1,583,293,444 +$44,287,843 $24.81 202
2016 Q3 65,109,145 $1,468,647,032 -$90,081,305 $22.57 190
2016 Q2 68,936,606 $1,642,725,804 +$6,756,500 $23.83 201
2016 Q1 69,341,664 $1,645,756,412 +$49,366,449 $23.75 198
2015 Q4 66,948,736 $1,831,213,465 +$10,773,822 $27.82 184
2015 Q3 66,529,181 $1,374,516,977 +$82,444,843 $20.66 176
2015 Q2 61,400,204 $1,576,126,230 +$9,727,194 $25.67 171
2015 Q1 62,486,510 $1,576,780,729 +$33,822,037 $25.24 177
2014 Q4 61,020,215 $1,450,530,086 +$92,541,482 $23.77 180
2014 Q3 56,925,672 $1,119,594,205 +$39,748,812 $19.67 161
2014 Q2 53,953,797 $1,290,597,540 +$11,671,621 $23.92 173
2014 Q1 52,934,396 $1,405,244,236 +$57,491,990 $26.59 155